Abira Medical Laboratories, LLC v. CareSource, et al.

CourtDistrict Court, S.D. Ohio
DecidedJanuary 30, 2026
Docket3:24-cv-00157
StatusUnknown

This text of Abira Medical Laboratories, LLC v. CareSource, et al. (Abira Medical Laboratories, LLC v. CareSource, et al.) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Abira Medical Laboratories, LLC v. CareSource, et al., (S.D. Ohio 2026).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF OHIO WESTERN DIVISION AT DAYTON

ABIRA MEDICAL LABORATORIES, LLC,

Plaintiff, Case No. 3:24-cv-157

vs.

CARESOURCE, et al., District Judge Michael J. Newman Magistrate Judge Peter B. Silvain, Jr. Defendants.

______________________________________________________________________________

ORDER: GRANTING DEFENDANT CARESOURCE’S UNOPPOSED MOTION TO FILE DEPOSITION TESTIMONY AND EXHIBITS UNDER SEAL (Doc. No. 38) ______________________________________________________________________________

This matter comes before the Court on Defendant CareSource’s motion to file deposition testimony and exhibits under seal in support of Defendant CareSource's motion for summary judgment. Doc. No. 38. Pursuant to S.D. Ohio Civ. R. 5.2.1 and Shane Group, the Court finds that: (1) there is a compelling interest in maintaining the confidentiality of the Rule 30(b)(6) Deposition of Plaintiff Abira Medical Laboratories, LLC d/b/a Genesis Diagnostics (“Abira Deposition”) and its exhibits, including in protecting the protected health information (“PHI”) and personally identifiable information (“PII”) of third parties; (2) the interest in maintaining the confidentiality of the Abira Deposition and its exhibits outweighs the public’s interest in accessing them because the interest in the outcome of this matter is limited to the parties, and protecting the confidentiality of the Abira Deposition and its exhibits will not prejudice the public’s right to guard against corruption and the public’s right to be on notice about what is and what is not a violation of law; and (3) Defendant CareSource’s request is narrowly tailored because PHI and PII are central components of this litigation, and such information is pervasive throughout the documents, such that redaction is impracticable. See Shane Group, Inc. v. Blue Cross Blue Shield of Mich., 825 F.3d 299, 305 (6th Cir. 2016). Therefore, Defendant CareSource's motion is GRANTED. Defendant CareSource shall file the Abira Deposition and its exhibits UNDER SEAL in their entirety.

IT IS SO ORDERED. January 30, 2026 s/Michael J. Newman Hon. Michael J. Newman United States District Judge

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Abira Medical Laboratories, LLC v. CareSource, et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/abira-medical-laboratories-llc-v-caresource-et-al-ohsd-2026.